Lonneke Timmers
Lonneke Timmers publishes mostly in Economics and Econometrics, Family Practice and Oncology, on topics such as Health Systems, Economic Evaluations, Quality of Life, Medication Adherence and Compliance and Pharmaceutical Economics and Policy.
- World rank
- #2,659,724 of 7,710,434 ranked researchers
- Rank in Netherlands
- #55,617 of 107,149
- Works
- 68
- Citations
- 1k
- Citations per work
- 15.4
What does Lonneke Timmers research?
Lonneke Timmers's work is mostly in Medicine (39%), Economics, Econometrics and Finance (28%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2638.9%
- Medicine2638.9%
- Everything else2333.1%
- Social Sciences1928.0%
- 1Economics and Econometrics28% of their works
- 2Family Practice11% of their works
- 3Oncology9% of their works
- 4Pediatrics, Perinatology and Child Health7% of their works
- 5Hematology6% of their works
- 6Geriatrics and Gerontology6% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Medication Adherence and Compliance
- Pharmaceutical Economics and Policy
- Pharmaceutical studies and practices
- Pharmaceutical Practices and Patient Outcomes
- Economic and Financial Impacts of Cancer
- Chronic Myeloid Leukemia Treatments
- Biosimilars and Bioanalytical Methods
Which keywords describe Lonneke Timmers's research?
The keywords of their largest research topics: Medication Adherence, Cost-effectiveness Analysis, Quality of Life, Patient Compliance, Treatment Adherence, Drug Development Costs, Generic Drugs and Off-Label Drug Use.
- Biosimilars
- BCR-ABL
- Cost of Care
- Inappropriate Medication Use
- Off-Label Drug Use
- Drug Development Costs
- Patient Compliance
- Cost-effectiveness Analysis
- Medication Adherence
- Quality of Life
- Treatment Adherence
- Generic Drugs
- Pediatric Pharmacokinetics
- Polypharmacy
- Financial Toxicity
- Imatinib
- Immunogenicity
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Medication Adherence342 topics
- Cost-effectiveness Analysis261 topic
- Quality of Life261 topic
- Patient Compliance221 topic
- Treatment Adherence221 topic
- Drug Development Costs151 topic
- Generic Drugs151 topic
- Off-Label Drug Use121 topic
- Pediatric Pharmacokinetics121 topic
- Inappropriate Medication Use111 topic
- Polypharmacy111 topic
- Cost of Care101 topic
- Financial Toxicity101 topic
- BCR-ABL91 topic
- Imatinib91 topic
- Biosimilars51 topic
- Immunogenicity51 topic
Where does Lonneke Timmers work?
Lonneke Timmers's main affiliation in the publication record is Zorginstituut Nederland, Netherlands.
How many publications and citations does Lonneke Timmers have?
OpenAlex counts 68 works and 1,044 citations for Lonneke Timmers, an h-index of 16, ranking #2,659,724 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lonneke Timmers. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.